論文
2018 英文
TITLE & JOURNAL/AUTHORS
- Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice.
著者名：Thi Thanh Hai N, Thuy LTT, Shiota A, Kadono C, Daikoku A, Hoang DV, Dat NQ, Sato-Matsubara M, Yoshizato K, Kawada N.
出版物名：Sci Rep. 2018 Dec 14;8(1):17860. doi: 10.1038/s41598-018-36215-4.
- Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
著者名：Motoyama H, Tamori A, Kubo S, Uchida-Kobayashi S, Takemura S, Tanaka S, Ohfuji S, Teranishi Y, Kozuka R, Kawamura E, Hagihara A, Morikawa H, Enomoto M, Murakami Y, Kawada N.
出版物名：PLoS One. 2018 Mar 13;13(3):e0194163.
doi: 10.1371/journal.pone.0194163. eCollection 2018.
- The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor-naive patients with chronic HCV genotype 1b infection in a real-world cohort.
著者名：Kozuka R, Hai H, Motoyama H, Hagihara A, Fujii H, Uchida-Kobayashi S, Morikawa H, Enomoto M, Murakami Y, Kawada N, Tamori A.
出版物名：J Viral Hepat. 2018 May;25(5):535-542.
doi: 10.1111/jvh.12850. Epub 2018 Jan 17.
- Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis B.
著者名：Enomoto M, Nishiguchi S, Tamori A, Kozuka R, Fujii H, Uchida-Kobayashi S, Fukunishi S, Tsuda Y, Higuchi K, Saito M, Enomoto H, Kawada N.
出版物名：Hepatol Res. 2018 May;48(6):459-468.
doi: 10.1111/hepr.13050. Epub 2018 Feb 12.
- Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.
著者名：Kozuka R, Enomoto M, Sato-Matsubara M, Yoshida K, Motoyama H, Hagihara A, Fujii H, Uchida-Kobayashi S, Morikawa H, Tamori A, Kawada N, Murakami Y.
出版物名：J Gastroenterol Hepatol. 2018 Aug 30.
doi: 10.1111/jgh.14454. [Epub ahead of print]
- Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma.
著者名：Iida-Ueno A, Enomoto M, Uchida-Kobayashi S, Hagihara A, Teranishi Y, Fujii H, Morikawa H, Murakami Y, Tamori A, Thuy LTT, Kawada N.
出版物名：Cancer Chemother Pharmacol. 2018 Nov;82(5):857-864.
doi: 10.1007/s00280-018-3681-x. Epub 2018 Sep 3.
- Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy.
著者名：Tamori A, Abiru S, Enomoto H, Kioka K, Korenaga M, Tani J, Enomoto M, Sugiyama M, Masaki T, Kawada N, Yatsuhashi H, Nishiguchi S, Mizokami M.
出版物名：J Viral Hepat. 2018 May;25(5):608-611.
doi: 10.1111/jvh.12840. Epub 2017 Dec 28.
- Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.
著者名：Enomoto M, Tateishi C, Tsuruta D, Tamori A, Kawada N.
出版物名：Ann Intern Med. 2018 May 1;168(9):678-680.
doi: 10.7326/L17-0613. Epub 2018 Jan 16.
- Pancreatic Cancer Cell Fraction Estimation in a DNA Sample.
著者名：Ishihara H, Yamashita S, Amano R, Kimura K, Hirakawa K, Ueda T, Murakami Y, Tamori A, Tanabe K, Kawada N, Hagihara A, Ushijima T.
出版物名：Oncology. 2018 Aug 27:1-10.
doi: 10.1159/000491637. [Epub ahead of print]
- Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis: A retrospective observational study.
著者名：Kotani K, Kawabe J, Higashiyama S, Yoshida A, Kawamura E, Tamori A, Shiomi S, Kawada N.
出版物名：Medicine (Baltimore). 2018 Aug;97(31):e11765.
doi: 10.1097/MD.0000000000011765.
- A Clinical Quantitative Evaluation of Hepatobiliary Transport of Dehydropravastatin in Humans Using Positron Emission Tomography.
著書名：Kaneko K, Tanaka M, Ishii A, Katayama Y, Nakaoka T, Irie S, Kawahata H, Yamanaga T, Wada Y, Miyake T, Toshimoto K, Maeda K, Cui Y, Enomoto M, Kawamura E, Kawada N, Kawabe J, Shiomi S, Kusuhara H, Sugiyama Y, Watanabe Y.
出版物名：Drug Metab Dispos. 2018 May;46(5):719-728.
doi: 10.1124/dmd.118.080408. Epub 2018 Mar 19.
- Association between Functional Dyspepsia and Gastric Depressive Erosions in Japanese Subjects.
著者名: Tanaka F, Tominaga K, Fujikawa Y, Morisaki T, Otani K, Hosomi S, Nagami Y, Kamata N, Taira K, Nakano A, Kimura T, Yamagami H, Tanigawa T, Morikawa H, Fukumoto S, Watanabe T, Kawada N, Hirata K, Fujiwara Y.
出版物名: Intern Med. 2018 Sep 12.
doi: 10.2169/internalmedicine.1325-18. [Epub ahead of print]
- Immunohistochemical characterization of cancer-associated fibroblasts at the primary sites and in the metastatic lymph nodes of human intrahepatic cholangiocarcinoma.
著者名：Itou RA, Uyama N, Hirota S, Kawada N, Wu S, Miyashita S, Nakamura I, Suzumura K, Sueoka H, Okada T, Hatano E, Tsutsui H, Fujimoto J.
出版物名: Hum Pathol. 2018 Aug 30. pii: S0046-8177(18)30331-9.
doi: 10.1016/j.humpath.2018.08.016. [Epub ahead of print]
- The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease.
著者名：Katayama K, Kawaguchi T, Shiraishi K, Ito T, Suzuki K, Koreeda C, Ohtake T, Iwasa M, Tokumoto Y, Endo R, Kawamura N, Shiraki M, Hanai T, Habu D, Tsuruta S, Sakai H, Miwa Y, Kawada N, Kato A, Takei Y, Mine T, Kohgo Y, Seki T, Sata M, Ito Y, Fukui K, Nishiguchi S, Moriwaki H, Suzuki K.
出版物名：J Clin Med Res. 2018 May;10(5):437-444.
doi: 10.14740/jocmr3374w. Epub 2018 Mar 16.
- Ledipasvir-sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection.
著者:Asahina Y, Itoh Y, Ueno Y, Matsuzaki Y, Takikawa Y, Yatsuhashi H, Genda T, Ikeda F, Matsuda T, Dvory-Sobol H, Jiang D, Massetto B, Osinusi AO, Brainard DM, McHutchison JG, Kawada N, Enomoto N.
出版物名:Liver Int. 2018 Sep;38(9):1552-1561.
doi: 10.1111/liv.13685. Epub 2018 Jun 29.
- Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial.
著書名：Takehara T, Sakamoto N, Nishiguchi S, Ikeda F, Tatsumi T, Ueno Y, Yatsuhashi H, Takikawa Y, Kanda T, Sakamoto M, Tamori A, Mita E, Chayama K, Zhang G, De-Oertel S, Dvory-Sobol H, Matsuda T, Stamm LM, Brainard DM, Tanaka Y, Kurosaki M.
出版物名：J Gastroenterol. 2018 Sep 10.
doi: 10.1007/s00535-018-1503-x. [Epub ahead of print]
- Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
著書名：Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K.
出版物名：Sci Rep. 2018 May 21;8(1):7958.
doi: 10.1038/s41598-018-26217-7.
- Quasispecies variant of pre-S/S gene in HBV-related hepatocellular carcinoma with HBs antigen positive and occult infection.
著書名：Hatazawa Y, Yano Y, Okada R, Tanahashi T, Hayashi H, Hirano H, Minami A, Kawano Y, Tanaka M, Fukumoto T, Murakami Y, Yoshida M, Hayashi Y.
出版物名：Infect Agent Cancer. 2018 Feb 2;13:7.
doi: 10.1186/s13027-018-0179-4. eCollection 2018.
- Mechanism of recipient cell-dependent differences in exosome uptake.
著書名：NHoribe S, Tanahashi T, Kawauchi S, Murakami Y, Rikitake Y.
出版物名：BMC Cancer. 2018 Jan 6;18(1):47.
doi: 10.1186/s12885-017-3958-1.
- Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.
著書名：Matsumoto A, Nishiguchi S, Enomoto H, Kang JH, Tanaka Y, Shinkai N, Kurosaki M, Enomoto M, Kanda T, Yokosuka O, Yatsuhashi H, Nagaoka S, Okuse C, Kagawa T, Mine T, Takaguchi K, Saito S, Hino K, Ikeda F, Sakisaka S, Morihara D, Miyase S, Tsuge M, Chayama K, Hiramatsu N, Suzuki Y, Murata K, Tanaka E.
出版物名：J Gastroenterol. 2018 Feb;53(2):247-257.
doi: 10.1007/s00535-017-1360-z. Epub 2017 Jun 20.
- A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD.
著書名：Kawaguchi T, Tokushige K, Hyogo H, Aikata H, Nakajima T, Ono M, Kawanaka M, Sawada K, Imajo K, Honda K, Takahashi H, Mori K, Tanaka S, Seko Y, Nozaki Y, Kamada Y, Fujii H, Kawaguchi A, Takehara T, Yanase M, Sumida Y, Eguchi Y, Seike M, Yoneda M, Suzuki Y, Saibara T, Karino Y, Chayama K, Hashimoto E, George J, Torimura T.
出版物名: Sci Rep. 2018 Jul 11;8(1):10434.
doi: 10.1038/s41598-018-28650-0.
- The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study.
著書名：Ishiba H, Sumida Y, Tanaka S, Yoneda M, Hyogo H, Ono M, Fujii H, Eguchi Y, Suzuki Y, Yoneda M, Takahashi H, Nakahara T, Seko Y, Mori K, Kanemasa K, Shimada K, Imai S, Imajo K, Kawaguchi T, Nakajima A, Chayama K, Saibara T, Shima T, Fujimoto K, Okanoue T, Itoh Y; Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD).
出版物名：J Gastroenterol. 2018 Nov;53(11):1216-1224.
doi: 10.1007/s00535-018-1474-y. Epub 2018 May 9.
- Prevalence of pruritus in patients with chronic liver disease: A multicenter study.
著者名：Oeda S, Takahashi H, Yoshida H, Ogawa Y, Imajo K, Yoneda M, Koshiyama Y, Ono M, Hyogo H, Kawaguchi T, Fujii H, Nishino K, Sumida Y, Tanaka S, Kawanaka M, Torimura T, Saibara T, Kawaguchi A, Nakajima A, Eguchi Y; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).
出版物名:Hepatol Res. 2018 Feb;48(3):E252-E262.
doi: 10.1111/hepr.12978. Epub 2017 Oct 10.
- Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status.
著書名：Koda M, Tanaka S, Takemura S, Shinkawa H, Kinoshita M, Hamano G, Ito T, Kawada N, Shibata T, Kubo S.
出版物名： Liver Cancer. 2018 Sep;7(3):261-276.
doi: 10.1159/000486902. Epub 2018 Mar 13.
- Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C.
著書名：Enomoto M, Ikura Y, Tamori A, Kozuka R, Motoyama H, Kawamura E, Hagihara A, Fujii H, Uchida-Kobayashi S, Morikawa H, Murakami Y, Kawada N.
出版物名： United European Gastroenterol J. 2018 Nov;6(9):1391-1400.
doi: 10.1177/2050640618791053. Epub 2018 Jul 19.
- Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virus.
著書名：Okada M, Hai H, Tamori A, Uchida-Kobayashi S, Enomoto M, Kumada H, Kawada N.
出版物名： Clin J Gastroenterol. 2018 Nov 16. doi: 10.1007/s12328-018-0922-9. [Epub ahead of print]
- Quasispecies variant of pre-S/S gene in HBV-related hepatocellular carcinoma with HBs antigen positive and occult infection.
著書名：Hatazawa Y, Yano Y, Okada R, Tanahashi T, Hayashi H, Hirano H, Minami A, Kawano Y, Tanaka M, Fukumoto T, Murakami Y, Yoshida M, Hayashi Y.
出版物名： Infect Agent Cancer. 2018 Feb 2;13:7.
doi: 10.1186/s13027-018-0179-4. eCollection 2018.
- Early change in quasispecies variant after antiviral therapy for chronic hepatitis B.
著書名：Liang Y, Yano Y, Putri W, Mardian Y, Okada R, Tanahashi T, Murakami Y, Hayashi Y.
出版物名： Mol Med Rep. 2018 Apr;17(4):5528-5537.
doi: 10.3892/mmr.2018.8551. Epub 2018 Feb 2.
- Involvement of ERK1/2 activation in the gene expression of senescence-associated secretory factors in human hepatic stellate cells.
著書名：Odagiri N, Matsubara T, Higuchi M, Takada S, Urushima H, Sato-Matsubara M, Teranishi Y, Yoshizato K, Kawada N, Ikeda K.
出版物名:Mol Cell Biochem. 2018 Nov 13. doi: 10.1007/s11010-018-3466-x. [Epub ahead of print]
2018 和文
タイトル・著者
- 【肝胆膵とアルコール-serendipityを目指して-】 アルコール性肝障害の肝細胞障害機序 肝線維化進展機構(解説/特集)
Author：藤井 英樹(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 河田 則文
Source： 肝・胆・膵 (0389-4991)76巻1号 Page33-39(2018.01)
- 【肝癌撲滅に向けたわが国の取り組み-厚労省、地方自治体、拠点病院の連携】 大阪府の取り組み 医療従事者への啓発(解説/特集))
Author：榎本 大(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 打田 佐和子, 藤井 英樹, 河田 則文
Source： 消化器・肝臓内科 (2432-3446)3巻3号 Page324-329(2018.03)
- 【肝線維化をcatch】 肝線維化のメカニズム(解説/特集)
Author：小田桐 直志(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 松原 三佐子, 河田 則文
Source： 臨床検査 (0485-1420)62巻5号 Page586-592(2018.05)
- 【診断と治療のABC[131]肝硬変】 (第2章)病態生理 肝線維化(解説/特集)
Author：湯川 芳美(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 河田 則文
Source： 最新医学 (0370-8241)別冊肝硬変 Page35-43(2018.02)
- 医学と医療の最前線 肝線維化の分子病態と最新治療(解説)
Author：河田 則文(大阪市立大学 大学院医学研究科肝胆膵病態内科学)
Source： 日本内科学会雑誌 (0021-5384)107巻5号 Page938-943(2018.05)
- 【NAFLD/NASH診療のイノベーション-ガイドラインからパイプラインへ】NAFLD/NASH診断:現在のコンセンサスを知る ノンアルコールとは 飲酒量をどう評価する?(解説/特集)
author: 藤井 英樹(大阪市立大学 大学院医学研究科肝胆膵病態内科学)
source: 内科 (0022-1961)121巻6号 Page1283-1288(2018.06)
- 門脈圧亢進症(解説)
author: 元山 宏行(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 河田 則文
source: 消化器の臨床 (1344-3070)21巻3号 Page152-158(2018.08)
- 肝疾患の診断と治療 進化したElastographyとRVSの活用(解説)
author: 森川 浩安(大阪市立大学 医学部肝胆膵病態内科学・先端予防医療学)
source: INNERVISION (0913-8919)33巻9号 Page94-95(2018.08)
- 肝疾患の診断から治療 進化したRVSの活用(解説)
author: 打田 佐和子(大阪市立大学 大学院医学研究科肝胆膵病態内科学)
source: INNERVISION (0913-8919)33巻9号 Page96-97(2018.08)
- 【先端医療シリーズ 49 消化器疾患の最新医療】第16章 間疾患における新薬開発の動向、肝硬変、肝線維化
author: 松原 三佐子(大阪市立大学 大学院医学研究科肝胆膵病態内科学), 河田 則文
source: 先端医療技術研究所 Page214－219 (2018.08)
